Pliant Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €12.84M +0.0% -€161.73M -0.5% -1,259.5% +0.068 pp N/A N/A
    (estimated) €12.84M +200.0% -€162.61M +32.3% -1,266.3% +16 pp N/A N/A
    (estimated) €4.28M +133.6% -€122.91M +4.1% -2,871.4% +36 pp -€118.14M -2.1% -2,760.0% +38 pp
    (estimated) €1.83M -14.4% -€118.12M -14.9% -6,447.7% +0.37 pp -€120.71M -12.4% -6,588.8% -1.5 pp
    (estimated) €2.14M +∞% -€138.79M -22.9% -6,484.8% -65 pp -€137.83M +6.2% -6,440.0% -64 pp
    €0.00 -100.0% -€180.04M +30.4% N/A -€129.83M +31.4% N/A
    €1.35M -83.7% -€138.12M +32.8% -10,211.1% -90 pp -€98.83M +24.3% -7,306.3% -63 pp
    €8.29M +27.9% -€104.01M +578.5% -1,254.5% -10 pp -€79.51M +26.4% -958.9% +0.12 pp
    €6.48M -81.9% -€15.33M -54.9% -236.5% -1.4 pp -€62.91M +105.6% -970.5% -8.9 pp
    €35.80M -26.7% -€34.03M -21,583.8% -95.0% -0.95 pp -€30.60M +1,901.1% -85.5% -0.82 pp
    €48.84M +∞% €158.38K -100.6% 0.3% +0.0032 pp -€1.53M -93.1% -3.1% -0.031 pp
    €0.00 +NaN% -€25.92M +46.8% N/A -€22.26M +67.6% N/A
    €0.00 -€17.65M N/A -€13.29M N/A

    Notifications